The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer's disease

Microglia are resident immune cells in the central nervous system. During the pathogenesis of Alzheimer's disease, stimulatory factors continuously act on the microglia causing abnormal activation and unbalanced phenotypic changes; these events have become a significant and promising area of research. In this review, we summarize the effects of microglial polarization and crosstalk with other cells in the central nervous system in the treatment of Alzheimer's disease. Our literature search found that phenotypic changes occur continuously in Alzheimer's disease and that microglia exhibit extensive crosstalk with astrocytes, oligodendrocytes, neurons, and penetrated peripheral innate immune cells via specific signaling pathways and cytokines. Collectively, unlike previous efforts to modulate microglial phenotypes at a single level, targeting the phenotypes of microglia and the crosstalk with other cells in the central nervous system may be more effective in reducing inflammation in the central nervous system in Alzheimer's disease. This would establish a theoretical basis for reducing neuronal death from central nervous system inflammation and provide an appropriate environment to promote neuronal regeneration in the treatment of Alzheimer's disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:18

Enthalten in:

Neural regeneration research - 18(2023), 5 vom: 27. Mai, Seite 947-954

Sprache:

Englisch

Beteiligte Personen:

Wu, Yi-Ge [VerfasserIn]
Song, Li-Juan [VerfasserIn]
Yin, Li-Jun [VerfasserIn]
Yin, Jun-Jun [VerfasserIn]
Wang, Qing [VerfasserIn]
Yu, Jie-Zhong [VerfasserIn]
Xiao, Bao-Guo [VerfasserIn]
Ma, Cun-Gen [VerfasserIn]

Links:

Volltext

Themen:

Alzheimer’s disease
Amyloid
Biomarker
Central nervous system
Cytokines
Diabetes
Inflammation
Journal Article
Microglia
Neuroinflammation
Phagocytosis
Review
Tau

Anmerkungen:

Date Revised 11.01.2023

published: Print

Citation Status PubMed-not-MEDLINE

doi:

10.4103/1673-5374.355747

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM347698387